South & Central America Clinical Trials Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)

No. of Pages: 125    |    Report Code: BMIRE00029015    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Clinical Trials Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Clinical Trials Market – By Phase

1.3.2        South & Central America Clinical Trials Market – By Study Design

1.3.3        South & Central America Clinical Trials Market – By Indication

1.3.4        South & Central America Clinical Trials Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central America Clinical Trials Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South And Central America PEST Analysis

4.3         Experts Opinion

5.           South & Central America Clinical Trials Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Adoption and Outsourcing of Clinical Trials

5.1.2        Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry

5.2         Market Restraints

5.2.1        Expensive and Time-Consuming Process

5.3         Market Opportunities

5.3.1        Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials

5.4         Future Trends

5.4.1        AI-Driven Clinical Trials

5.5         Impact Analysis

6.           Clinical Trials Market – South & Central America Analysis

6.1         South & Central America Clinical Trials Market Revenue Forecast and Analysis

7.           South & Central America Clinical Trials Market Revenue and Forecast To 2028 – by Study Design

7.1         Overview

7.2         South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

7.3         Interventional

7.3.1        Overview

7.3.2        Interventional: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Observational

7.4.1        Overview

7.4.2        Observational: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Expanded Access

7.5.1        Overview

7.5.2        Expanded Access: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.           South & Central America Clinical Trials Market – By Phase

8.1         Overview

8.2         South & Central America Clinical Trials Market, by Phase, 2022 and 2028 (%)

8.3         Phase III

8.3.1        Overview

8.3.2        Phase III: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Phase II

8.4.1        Overview

8.4.2        Phase II: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Phase IV

8.5.1        Overview

8.5.2        Phase IV: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Phase I

8.6.1        Overview

8.6.2        Phase I: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.           South & Central America Clinical Trials Market Revenue and Forecast To 2028 – Indication

9.1         Overview

9.2         South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

9.3         Autoimmune/Inflammation

9.3.1        Overview

9.3.2        Autoimmune/Inflammation: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Pain Management

9.4.1        Overview

9.4.2        Pain Management: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Oncology

9.5.1        Overview

9.5.2        Oncology: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.6         CNS Condition

9.6.1        Overview

9.6.2        CNS Condition: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Diabetes

9.7.1        Overview

9.7.2        Diabetes: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.8         Obesity

9.8.1        Overview

9.8.2        Obesity: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.9         Cardiovascular

9.9.1        Overview

9.9.2        Cardiovascular: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.10      Other

9.10.1     Overview

9.10.2     Other: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.        South & Central America Clinical Trials Market – Revenue and Forecast to 2028 – Country Analysis

10.1    South & Central America Clinical Trials Market

10.1.1     Overview

10.1.2     South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)

10.1.2.1       Brazil: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       Brazil: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       Brazil: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.2.1.4       Brazil: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.2.1.5       Brazil: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

10.1.2.2       Argentina: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       Argentina: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       Argentina: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.2.2.4       Argentina: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.2.2.5       Argentina: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

10.1.2.3       Rest of South & Central America: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       Rest of South & Central America: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       Rest of South & Central America: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.2.3.4       Rest of South & Central America: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)

10.1.2.3.5       Rest of South & Central America: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies Done by the Companies in the Market, (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      IQVIA Holdings Inc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Parexel International Corp

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Charles River Laboratories International Inc

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      ICON Plc

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      SGS SA

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Syneos Health Inc

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Thermo Fisher Scientific Inc

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6

12.7.7     Key Developments

12.8      Laboratory Corp of America Holdings

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

LIST OF TABLES

Table 1.             Brazil Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Argentina Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Argentina Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Rest of South & Central America Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Rest of South & Central America Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Rest of South & Central America Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Organic Developments Done by Companies

Table 11.          Inorganic Developments Done by Companies

Table 12.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           South & Central America Clinical Trials Market Segmentation

Figure 2.           South & Central America Clinical Trials Market, By Region

Figure 3.           South & Central America Clinical Trials Market Overview

Figure 4.           Phase III Segment Held Largest Share of Phase Segment in South & Central America Clinical Trials Market

Figure 5.           Argentina is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           South And Central America: PEST Analysis

Figure 7.           South & Central America Experts Opinion

Figure 8.           Impact Analysis

Figure 9.           South & Central America Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

Figure 11.        Interventional: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Observational: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Expanded Access: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        South & Central America Clinical Trials Market, by Phase 2022 and 2028 (%)

Figure 15.        Phase III: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Phase II: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Phase IV: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Phase I: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

Figure 20.        Autoimmune/Inflammation: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Pain Management: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Oncology: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        CNS Condition: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Diabetes: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Obesity: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cardiovascular: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        South & Central America: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)

Figure 29.        South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)

Figure 30.        Brazil: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Argentina: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Rest of South & Central America: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Growth Strategies Done by the Companies in the Market, (%) 

The List of Companies - South & Central America Clinical Trials Market

  1. Charles River Laboratories International Inc
  2. ICON Plc
  3. IQVIA Holdings Inc
  4. Laboratory Corp of America Holdings
  5. Parexel International Corp
  6. SGS SA
  7. Syneos Health Inc
  8. Thermo Fisher Scientific Inc